Search Results - Bergenstal, Richard M, Dr

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

    Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial by Bergenstal, Richard M, Dr, Wysham, Carol, MD, MacConell, Leigh, PhD, Malloy, Jaret, PhD, Walsh, Brandon, PhD, Yan, Ping, PhD, Wilhelm, Ken, MD, Malone, Jim, MD, Porter, Lisa E, MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

    Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study by Drucker, Daniel J, Dr, Buse, John B, MD, Taylor, Kristin, PhD, Kendall, David M, MD, Trautmann, Michael, MD, Zhuang, Dongliang, PhD, Porter, Lisa, MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: